Department of Neurology, Virginia Commonwealth University Health, Richmond, Virginia, USA.
Department of Pediatric Neurology, University of Utah, Salt Lake City, Utah, USA.
Muscle Nerve. 2021 Mar;63(3):384-391. doi: 10.1002/mus.27147. Epub 2021 Jan 10.
We aim to describe 12-mo functional and motor outcome performance in a cohort of participants with congenital myotonic dystrophy (CDM).
CDM participants performed the 6 Minute Walk Test (6MWT), 10 Meter Run, 4 Stair Climb, Grip Strength, and Lip Force at baseline and 12-mo visits. Parents completed the Vineland Adaptive Behavior Scale.
Forty-seven participants, aged 0 to 13 y old, with CDM were enrolled. 6MWT, 10 Meter Run, and 4 Stair Climb were completed in >85% of eligible participants. The only significant difference between mean baseline and 12-mo performance was an improvement in 6MWT in children 3-6 y old (P = .008). This age group also had the largest mean % improvement in performance in all other timed functional testing. In children >7 y, the slope of change on timed functional tests decreased or plateaued, with further reductions in performance in children ≥10 y. Participants with CTG repeat lengths <500 did not perform differently than those with repeat lengths >1000.
The 6MWT, 10 Meter Run, and 4 Stair Climb were the most feasible measures. Our findings are consistent with the clinical profile and prior cross-sectional data, helping to establish reasonable expectations of functional trajectories in this population as well as identifying points in which therapeutic interventions may be best studied. Further study of outcomes in children >10 y old and <3 y is warranted, but this new information will assist planning of clinical trials in the CDM population.
我们旨在描述一组先天性肌强直性营养不良(CDM)患者在 12 个月时的功能和运动结局表现。
CDM 患者在基线和 12 个月访视时进行 6 分钟步行测试(6MWT)、10 米跑、4 级爬楼梯、握力和唇力测试。家长完成了适应行为量表。
共纳入 47 名年龄在 0 至 13 岁的 CDM 患者。6MWT、10 米跑和 4 级爬楼梯在>85%的合格参与者中完成。平均基线和 12 个月时表现之间唯一显著差异是 3-6 岁儿童的 6MWT 改善(P =.008)。该年龄组在所有其他计时功能测试中表现的平均百分比改善最大。在>7 岁的儿童中,计时功能测试的变化斜率降低或趋于平稳,≥10 岁的儿童的表现进一步下降。CTG 重复长度<500 的参与者与重复长度>1000 的参与者的表现没有差异。
6MWT、10 米跑和 4 级爬楼梯是最可行的测量方法。我们的发现与临床特征和以前的横断面数据一致,有助于为该人群建立合理的功能轨迹预期,并确定治疗干预的最佳研究点。需要进一步研究>10 岁和<3 岁儿童的结局,但这些新信息将有助于 CDM 人群临床试验的规划。